Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study
Abstract Medication-related osteonecrosis of the jaw (MRONJ) is a refractory osteonecrosis caused by antiresorptive agents such as bisphosphonate and denosumab (DMB). In MRONJ surgery, computed tomography (CT) is generally used to determine the extent of bone resection. However, in some recent MRONJ...
Main Authors: | Yuki Sakamoto, Shunsuke Sawada, Yuka Kojima |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-39755-6 |
Similar Items
-
Drug holiday of high-dose denosumab and recovery from osteoclast inhibition using immunohistochemical investigation of 7 patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy
by: Shunsuke Sawada, et al.
Published: (2023-10-01) -
Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
by: Kohei Okuyama, et al.
Published: (2021-07-01) -
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients
by: Sakiko Soutome, et al.
Published: (2021-08-01) -
Medication-related osteonecrosis of the jaw: Prosthodontic considerations
by: Islam E. Ali, et al.
Published: (2022-11-01) -
THE USE OF CONE BEAM COMPUTED TOMOGRAPHY IN THE DIAGNOSIS AND TREATMENT OF MEDICATION-RELATED OSTEONECROSIS OF THE JAW
by: Mihai Liviu Ciofu, et al.
Published: (2015-07-01)